https://glpletter.com 2026-09-22T18:30:14.012Z daily 1 https://glpletter.com/sections/drug-delivery-beyond-injections 2026-09-10T01:07:47.897Z weekly 0.5 https://glpletter.com/sections/emerging-glp-1-indications 2026-08-27T17:36:39.147Z weekly 0.5 https://glpletter.com/sections/glp-1-science-and-mechanisms 2026-08-13T19:23:42.899Z weekly 0.5 https://glpletter.com/sections/glp-1-side-effects-and-patient-experience 2026-09-19T19:19:15.959Z weekly 0.5 https://glpletter.com/sections/nose-to-brain-n2b-delivery 2026-09-22T18:30:14.012Z weekly 0.5 https://glpletter.com/sections/nanoparticle-and-peptide-therapeutics 2026-08-06T22:07:53.755Z weekly 0.5 https://glpletter.com/authors/andre-nair 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/clara-ashworth 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/cora-ibrahim 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/dara-chen 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/diego-nakamura 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/dmitri-sinclair 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/elias-kowalski 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/elias-mbeki 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/emeka-contreras 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/estelle-ibrahim 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/estelle-vance 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/ezra-sabatini 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/felix-chen 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/felix-s-rensen 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/freya-ashworth 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/jonah-voss 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/julian-bennett 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/julian-ford 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/kai-mbeki 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/kai-park 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/kai-vance 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/kwame-delgado 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/leila-alvarez 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/lena-bergstrom 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/lena-contreras 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/lucia-nair 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/lucia-zola 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/malik-sinclair 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/maya-vance 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/nadia-yamada 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/naomi-osei 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/nico-bergstrom 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/nico-zola 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/priya-costa 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/priya-rossi 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/rafael-ford 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/rafael-ibrahim 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/rohan-park 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/rosa-rahman 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/rosa-wexler 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/selin-ibrahim 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/selin-yamada 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/simone-contreras 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/sofia-ashworth 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/sofia-whitfield 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/soren-kowalski 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/authors/vera-ashworth 2026-09-22T18:30:14.012Z weekly 0.4 https://glpletter.com/posts/nose-to-brain-delivery-in-neurodegenerative-disease-research https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/ef1640ce-3d07-45ad-a5c9-403722477fa2.jpeg 2026-09-22T18:30:14.012Z monthly 0.7 https://glpletter.com/posts/nose-to-brain-delivery-for-large-molecule-biologics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/8d26b583-3576-400b-a859-89423902f4c2.jpeg 2026-09-20T18:49:21.936Z monthly 0.7 https://glpletter.com/posts/glp-1-side-effect-profile-and-treatment-discontinuation-rates https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/d11f6113-a0de-4cca-9cdf-400e52207ab1.jpeg 2026-09-19T19:19:15.959Z monthly 0.7 https://glpletter.com/posts/gastroparesis-risk-with-glp-1-agonist-use https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/f69fa05d-8a3a-4e8b-877b-cc0b1a3ebb1a.jpeg 2026-09-18T19:50:22.786Z monthly 0.7 https://glpletter.com/posts/glp-1-skin-and-hypersensitivity-reactions https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/21aefb6b-e168-42c8-a1a9-926876c05a0c.jpeg 2026-09-16T18:45:41.485Z monthly 0.7 https://glpletter.com/posts/glp-1-side-effects-after-stopping-treatment https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/cfec1511-68a9-43fe-8298-fa92f368591b.png 2026-09-15T23:33:53.970Z monthly 0.7 https://glpletter.com/posts/glp-1-gastrointestinal-mechanisms-behind-nausea-and-diarrhea https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/3bdc891d-b739-4f5e-949f-df82768ce51d.jpeg 2026-09-15T22:29:07.383Z monthly 0.7 https://glpletter.com/posts/glp-1-injection-site-reactions-and-subcutaneous-tissue-effects https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/a8ff8f11-65dc-4606-8a60-0f83f6f40e96.jpeg 2026-09-13T03:36:24.482Z monthly 0.7 https://glpletter.com/posts/duration-and-resolution-of-glp-1-nausea-and-vomiting https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/12ffa5f2-b1ed-4291-bec5-2e29f6952785.jpeg 2026-09-12T03:42:26.433Z monthly 0.7 https://glpletter.com/posts/glp-1-long-term-side-effects-in-chronic-users https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/7bd62b3f-9cb4-488f-8d8e-90552e674a95.jpeg 2026-09-11T03:27:48.434Z monthly 0.7 https://glpletter.com/posts/patient-adherence-measurement-methods-in-chronic-peptide-therapy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/d9390c51-ab58-45d7-a907-133b657504ca.jpeg 2026-09-10T01:07:47.897Z monthly 0.7 https://glpletter.com/posts/sublingual-and-buccal-peptide-delivery-feasibility https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/897181b8-e4ee-46a9-952d-fabf55e0ec34.jpeg 2026-09-08T22:29:03.073Z monthly 0.7 https://glpletter.com/posts/long-acting-injectable-formulations-and-implantable-depots https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/da440118-85d0-4e36-b629-b643673bcf29.jpeg 2026-09-08T05:25:23.982Z monthly 0.7 https://glpletter.com/posts/transdermal-peptide-delivery-research-and-current-limits https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/3b6157f5-29cc-46fb-8019-ae40fd0a007b.jpeg 2026-09-05T21:48:15.886Z monthly 0.7 https://glpletter.com/posts/transdermal-peptide-delivery-technologies-in-development https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/6c5bc15f-c697-44f0-bbcd-df4075f7be05.jpeg 2026-09-04T18:45:15.569Z monthly 0.7 https://glpletter.com/posts/needle-aversion-and-injection-anxiety-in-chronic-disease-management https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/834b3ecf-33fe-4392-b5a1-7ddb84f4255a.jpeg 2026-09-03T18:44:42.887Z monthly 0.7 https://glpletter.com/posts/peptide-bioavailability-benchmarks-across-delivery-routes https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/996ab5d3-9bcf-43a0-8907-c10d222cf2ac.jpeg 2026-09-01T21:14:05.306Z monthly 0.7 https://glpletter.com/posts/injection-fatigue-and-device-innovation-in-biologic-delivery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/72ccf6d4-915e-44c1-ac93-3e57fd05d54c.jpeg 2026-08-30T17:47:10.568Z monthly 0.7 https://glpletter.com/posts/subcutaneous-vs-alternative-delivery-routes-for-glp-1-therapeutics https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/949dd588-b520-433a-af43-fb846989eeca.jpeg 2026-08-29T18:27:13.499Z monthly 0.7 https://glpletter.com/posts/oral-semaglutide-bioavailability-and-absorption-limitations https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/341f0100-ff63-4f6f-a604-ff14c35d6793.png 2026-08-28T19:31:21.893Z monthly 0.7 https://glpletter.com/posts/glp-1-and-cardiovascular-risk-reduction-mechanisms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/27fce4c4-3c16-4196-aa5c-db7248a74134.png 2026-08-27T17:36:39.147Z monthly 0.7 https://glpletter.com/posts/glp-1-agonists-in-non-alcoholic-fatty-liver-disease https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/9a832be3-b049-4489-ba2f-ee8b1dd98814.png 2026-08-26T21:52:26.944Z monthly 0.7 https://glpletter.com/posts/glp-1-effects-on-sleep-architecture-and-metabolic-recovery https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/8877f478-6f6a-4f23-971e-d25bd3400996.png 2026-08-25T19:32:45.448Z monthly 0.7 https://glpletter.com/posts/glp-1-receptors-in-nicotine-and-opioid-craving-reduction https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/19ed20ea-3dab-451d-be97-4903e61522a8.png 2026-08-25T17:18:39.162Z monthly 0.7 https://glpletter.com/posts/glp-1-agonists-and-parkinson-s-disease-neuroprotection https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/35167b36-0b1a-429f-b1cd-5a6e503b8687.png 2026-08-24T05:16:44.607Z monthly 0.7 https://glpletter.com/posts/glp-1-receptor-activation-and-opioid-craving-reduction https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/a6dc339d-8224-4986-9881-8463ebce9a12.png 2026-08-22T18:43:38.858Z monthly 0.7 https://glpletter.com/posts/obesity-brain-axis-and-hypothalamic-inflammation https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/4faff090-54b1-4796-a49b-8f0e7d965881.png 2026-08-21T17:48:44.693Z monthly 0.7 https://glpletter.com/posts/glp-1-drugs-and-parkinson-s-disease-neuroprotection https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/ababea63-bdf9-4588-8d83-3795ff13e6ea.png 2026-08-20T18:04:29.034Z monthly 0.7 https://glpletter.com/posts/glp-1-signaling-in-alzheimer-s-disease-models https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/a5274d45-4a21-40a9-81c7-e826d634b213.png 2026-08-19T17:28:29.578Z monthly 0.7 https://glpletter.com/posts/glp-1-signaling-in-alzheimer-s-disease-research https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/0a30bc06-90cb-4411-923f-274c63677e7b.png 2026-08-17T17:58:45.440Z monthly 0.7 https://glpletter.com/posts/glp-1-receptor-agonists-in-alcohol-use-disorder https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/c50d21ed-1dac-4039-b577-ab3ae5196b69.png 2026-08-16T17:28:28.702Z monthly 0.7 https://glpletter.com/posts/glp-1-receptors-and-dopamine-pathways-in-addiction https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/f07dd944-ebe2-49f2-8035-ad37cb00639a.png 2026-08-15T19:18:40.839Z monthly 0.7 https://glpletter.com/posts/glp-1-agonists-in-alcohol-use-disorder-research https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/cadd56a3-b954-4697-a2da-92d802eb63e1.png 2026-08-14T18:53:39.568Z monthly 0.7 https://glpletter.com/posts/dual-glp-1-gip-receptor-agonists-compared https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/2153fd8d-b66a-47fb-a019-a1af0f6a9a2c.png 2026-08-13T19:23:42.899Z monthly 0.7 https://glpletter.com/posts/gip-mechanism-of-action-in-weight-loss https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/719a2865-f410-4f18-b955-81fc3288300a.png 2026-08-12T18:18:35.486Z monthly 0.7 https://glpletter.com/posts/dpp-4-degradation-of-glp-1-and-half-life-engineering https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/3deeee0e-2d18-4656-9d63-7804fb44c7b3.png 2026-08-12T13:23:08.950Z monthly 0.7 https://glpletter.com/posts/glp-1-physiology-beyond-the-pancreas https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/2b8d80c9-c9bc-414b-906d-2315caa3a5e3.jpeg 2026-08-11T13:38:44.184Z monthly 0.7 https://glpletter.com/posts/glp-1-and-gip-combined-mechanism-of-action https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/951ed4f4-5c85-404a-ba85-014c2d06a8f8.jpeg 2026-08-10T13:38:41.323Z monthly 0.7 https://glpletter.com/posts/molecular-structure-of-glp-1-receptor-agonists https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/10dfa40d-b70d-47db-9e91-aeec9af27d9d.jpeg 2026-08-09T13:28:43.397Z monthly 0.7 https://glpletter.com/posts/glp-1-signaling-pathway-in-metabolic-regulation https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/e0a6fc3a-b0ba-4182-97bf-7989568e4f17.jpeg 2026-08-08T13:28:37.144Z monthly 0.7 https://glpletter.com/posts/engineering-precision-nanoparticles-for-peptide-payloads https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/976addf2-1b54-4f20-8a53-49d3bd1bdbb8.png 2026-08-06T22:07:53.755Z monthly 0.7 https://glpletter.com/posts/nose-to-brain-drug-delivery-pathway-explained https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/61c4beb4-3d2d-4d98-8c95-617dc4dec26b.jpeg 2026-08-06T21:18:44.484Z monthly 0.7 https://glpletter.com/posts/oral-peptide-delivery-and-the-intestinal-barrier-problem https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/6cd505b8-15bf-453c-839a-74dfc90c5622.jpeg 2026-08-06T21:18:41.658Z monthly 0.7 https://glpletter.com/posts/nausea-mechanisms-in-injectable-glp-1-therapy https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/73b7647f-8922-4c87-b61a-881443b9a860.jpeg 2026-08-06T21:18:41.169Z monthly 0.7 https://glpletter.com/posts/glp-1-receptors-in-the-brain https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/836acba8-dbd0-458c-8c50-716f2ffe20aa.jpeg 2026-08-06T21:13:38.798Z monthly 0.7 https://glpletter.com/posts/glp-1-injection-discontinuation-rates-and-their-causes https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/745781ca-e382-4232-aeea-cd3ac94c9462.jpeg 2026-08-06T20:53:44.856Z monthly 0.7 https://glpletter.com/posts/olfactory-pathway-anatomy-and-drug-transport-mechanisms https://mcxtywzsmeezbwapdahq.supabase.co/storage/v1/object/public/canvas-images/5f272d29-583f-45c8-b4b7-3112e4c46010/canvas/3eaf0fce-0722-45f9-a146-a0ed8b9027da/generated/b127dc5c-fb1f-4c02-9788-45adf70be8b0.jpeg 2026-08-06T20:53:44.119Z monthly 0.7